Dexcom Inc
(DXCM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 939,200 | 851,200 | 566,300 | 643,700 | 1,194,900 |
| Marketable Securities | 2,181,500 | 2,045,800 | 2,157,800 | 2,596,600 | 2,441,300 |
| Receivables | 945,200 | 978,600 | 973,900 | 785,700 | 750,600 |
| Inventories | 570,300 | 589,100 | 559,600 | 498,600 | 421,100 |
| TOTAL | $4,848,400 | $4,620,700 | $4,425,900 | $4,698,400 | $5,002,900 |
| Non-Current Assets | |||||
| PPE Net | 1,183,100 | 1,108,600 | 1,113,100 | 1,078,900 | 1,077,600 |
| Intangibles | 137,800 | 146,500 | 159,700 | 169,800 | 180,000 |
| Other Non-Current Assets | 629,900 | 606,400 | 565,800 | 649,100 | 560,200 |
| TOTAL | $1,950,800 | $1,861,500 | $1,838,600 | $1,897,800 | $1,817,800 |
| Total Assets | $6,799,200 | $6,482,200 | $6,264,500 | $6,596,200 | $6,820,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,569,800 | 1,446,600 | 1,345,500 | 1,373,100 | 1,156,500 |
| Accrued Expenses | 116,100 | 110,500 | 171,000 | 151,300 | 108,600 |
| TOTAL | $1,722,200 | $1,594,200 | $1,556,000 | $1,678,600 | $2,069,700 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,437,800 | 2,436,000 | 2,434,200 | 2,432,400 | 2,430,600 |
| Deferred Revenues | 14,700 | 16,400 | 18,400 | 9,000 | 9,000 |
| Other Non-Current Liabilities | 204,900 | 205,200 | 205,700 | 217,300 | 220,000 |
| TOTAL | $2,642,700 | $2,641,200 | $2,639,900 | $2,649,700 | $2,650,600 |
| Total Liabilities | $4,364,900 | $4,235,400 | $4,195,900 | $4,328,300 | $4,720,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 400,727 | 397,684 | 385,515 | 386,374 | 387,872 |
| Common Shares | 400 | 400 | 400 | 400 | 400 |
| Retained earnings | 1,311,300 | 1,167,800 | 1,021,400 | 765,100 | 644,400 |
| Other shareholders' equity | -37,700 | -37,000 | -16,800 | -35,600 | -29,400 |
| TOTAL | $2,434,300 | $2,246,800 | $2,068,600 | $2,267,900 | $2,100,400 |
| Total Liabilities And Equity | $6,799,200 | $6,482,200 | $6,264,500 | $6,596,200 | $6,820,700 |